+Vote!
Pharmalot (Free subscription) | yesterday
That’s one of a series of questions asked - yet again - about Genentech’s Avastin, which is approved for treating advanced lung, colon or breast cancer by cutting a tumor’s blood supply. The med is widely used, despite a price tag of up to $100,000 a year. Studies, however, show Avastin prolongs life by only [...]
+Vote!
GoozNews (Free subscription) | 05/07/2008
The New York Times on Sunday revisits the escalating controversy over the high cost of cancer care with a major story on Avastin, Genentech's blockbuster drug for colon, lung, and breast cancer that is already generating $2.3 billion a year...
+Vote!
Boston Globe (Free subscription) | 04/07/2008
The city of Boston is geared for a day of patriotic celebrations, culminating with the traditional July Fourth Boston Pops concert and fireworks display on the banks of the Charles River.
+Vote!
Life Science World (Free subscription) | 03/07/2008
[NEWS] MINNEAPOLIS, July 3 /PRNewswire/ — The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE® possessed DNA protective anti-mutagenic activity for human cells. This third party testing was performed as part of an ongoing investigative effort...
+Vote!
Market Wire (Free subscription) | 03/07/2008
GERMANTOWN, MD (MARKET WIRE) WeatherBug(R), the leading provider of live, local weather information and services, announced today they will provide local meteorological support for the 4th of July celebration on the Charles River Esplanade in Boston. Representatives from WeatherBug Professional will be positioned alongside more than 50 officials from federal, state and local agencies at the Unified...
+Vote!
Fiercebiotech (Free subscription) | 03/07/2008
Amgen was buoyed by the news that new data demonstrates that motesanib slowed the progression of metastatic thyroid cancer. Out of 93 patients in the study, 49 had a positive response. Volunteers with a BRAF V600E mutation did better than those without the mutation. Report
+Vote!
Medical News Today (Free subscription) | 03/07/2008
Illumina, Inc. (NASDAQ:ILMN) announced that researchers participating in a new initiative funded by the Wellcome Trust selected Illumina's Infinium HD BeadChips to analyze 90,000 DNA samples. This new initiative aims to decipher the molecular basis of human disease and includes participation from leading research groups around the globe.
+Vote!
LWN.net (Free subscription) | 03/07/2008
c|net reports on Invitrogen's switch to servers running SUSE Linux. " Invitrogen is a billion-dollar supplier to pharmaceutical and biotechnology companies, with 4,700 employees worldwide and a history of supplying many of the world's leading laboratories in groundbreaking research like the discovery of the AIDS virus. To help promote its innovative work, Invitrogen announced this week that it is standardizing...
1Vote!
Medical News Today (Free subscription) | 03/07/2008
Research conducted at The Walter and Eliza Hall Institute (WEHI) has contributed significantly to a major licensing agreement signed between Australian biotechnology company, Bionomics, (ASX:BNO) and Germany- based pharmaceutical company, Merck Serono.
+Vote!
Boston Globe (Free subscription) | 03/07/2008
In the Charles River, beyond the midday sunbathers, obscured from view by a slender island of trees, floats a network of sand-covered, metal barges filled with 16,000 pounds of explosives.